153 related articles for article (PubMed ID: 2314001)
1. [Effect of nutritional status on absorption kinetics of vitamin E in mucoviscidosis].
Skopnik H; Karl M; Kusenbach G; Bergt U; Geron M; Heimann G
Klin Padiatr; 1990; 202(1):43-9. PubMed ID: 2314001
[TBL] [Abstract][Full Text] [Related]
2. [Taurine supplementation in cystic fibrosis (CF): effect on vitamin E absorption kinetics].
Skopnik H; Kusenbach G; Bergt U; Friedrichs F; Stuhlsatz H; Döhmen H; Heimann G
Klin Padiatr; 1991; 203(1):28-32. PubMed ID: 2027264
[TBL] [Abstract][Full Text] [Related]
3. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
Dorlöchter L; Aksnes L; Fluge G
Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
[TBL] [Abstract][Full Text] [Related]
4. The occurrence and effects of human vitamin E deficiency. A study in patients with cystic fibrosis.
Farrell PM; Bieri JG; Fratantoni JF; Wood RE; di Sant'Agnese PA
J Clin Invest; 1977 Jul; 60(1):233-41. PubMed ID: 874086
[TBL] [Abstract][Full Text] [Related]
5. Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis.
Hakim F; Kerem E; Rivlin J; Bentur L; Stankiewicz H; Bdolach-Abram T; Wilschanski M
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):347-53. PubMed ID: 17873748
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E status in children with cystic fibrosis and pancreatic insufficiency.
Huang SH; Schall JI; Zemel BS; Stallings VA
J Pediatr; 2006 Apr; 148(4):556-559. PubMed ID: 16647424
[TBL] [Abstract][Full Text] [Related]
7. The clinical effect of correction of vitamin E depletion in cystic fibrosis.
Kelleher J; Miller MG; Littlewood JM; McDonald AM; Losowsky MS
Int J Vitam Nutr Res; 1987; 57(3):253-9. PubMed ID: 3679696
[TBL] [Abstract][Full Text] [Related]
8. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.
Durie PR; Forstner GG; Gaskin KJ; Moore DJ; Cleghorn GJ; Wong SS; Corey ML
Pediatr Res; 1986 Mar; 20(3):209-13. PubMed ID: 3703609
[TBL] [Abstract][Full Text] [Related]
9. Fat-soluble vitamin deficiency in children and adolescents with cystic fibrosis.
Rana M; Wong-See D; Katz T; Gaskin K; Whitehead B; Jaffe A; Coakley J; Lochhead A
J Clin Pathol; 2014 Jul; 67(7):605-8. PubMed ID: 24711511
[TBL] [Abstract][Full Text] [Related]
10. [Selenium and vitamin E in mucoviscidosis].
Foucaud P; Thérond P; Marchand M; Brion F; Demelier JF; Navarro J
Arch Fr Pediatr; 1988; 45(6):383-6. PubMed ID: 3219038
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid abnormalities in cystic fibrosis.
Farrell PM; Mischler EH; Engle MJ; Brown DJ; Lau SM
Pediatr Res; 1985 Jan; 19(1):104-9. PubMed ID: 3918287
[TBL] [Abstract][Full Text] [Related]
12. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D in infants with cystic fibrosis diagnosed by newborn screening.
Neville LA; Ranganathan SC
J Paediatr Child Health; 2009; 45(1-2):36-41. PubMed ID: 19208064
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E intake, α-tocopherol levels and pulmonary function in children and adolescents with cystic fibrosis.
Woestenenk JW; Broos N; Stellato RK; Arets HG; van der Ent CK; Houwen RH
Br J Nutr; 2015 Apr; 113(7):1096-101. PubMed ID: 25762411
[TBL] [Abstract][Full Text] [Related]
15. [Vitamin E: physiology and pathology].
Santini B; David O; Miniero R
Pediatr Med Chir; 1988; 10(1):25-30. PubMed ID: 3287349
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study.
Colombo C; Fredella C; Russo MC; Faelli N; Motta V; Valmarana L; Longo L; D'Orazio C
Pancreas; 2009 Aug; 38(6):693-9. PubMed ID: 19531972
[TBL] [Abstract][Full Text] [Related]
17. Self-reported use of vitamins and other nutritional supplements in adult patients with cystic fibrosis. Is daily practice in concordance with recommendations?
Hollander FM; de Roos NM; Dopheide J; Hoekstra T; van Berkhout FT
Int J Vitam Nutr Res; 2010 Dec; 80(6):408-15. PubMed ID: 21792821
[TBL] [Abstract][Full Text] [Related]
18. [Hypertocopherolemia in a patient with impaired tocopherol (vitamin E) absorption].
Ostrowski J
Pol Tyg Lek; 1981 Jan; 36(2):65-7. PubMed ID: 7243674
[No Abstract] [Full Text] [Related]
19. Response to a single oral dose of all-rac-alpha-tocopheryl acetate in patients with cystic fibrosis and in healthy individuals.
Winklhofer-Roob BM; Tuchschmid PE; Molinari L; Shmerling DH
Am J Clin Nutr; 1996 May; 63(5):717-21. PubMed ID: 8615354
[TBL] [Abstract][Full Text] [Related]
20. Syndrome of allergy, apraxia, and malabsorption: characterization of a neurodevelopmental phenotype that responds to omega 3 and vitamin E supplementation.
Morris CR; Agin MC
Altern Ther Health Med; 2009; 15(4):34-43. PubMed ID: 19623831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
